Roberto S.
- Country
- Italy
- Department
- U.O. Oncologia
Research Overview
- Efficacy of LY3537021 plus combination therapy versus placebo for chemotherapy-induced nausea and vomiting in adults with malignant disease
- A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)
Data & Insights
Has run more than one trial at 168 of 365 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating various forms of urological cancers, with particular emphasis on bladder cancer and prostate cancer management.
- Muscle-invasive bladder cancer treatment
- Non-muscle invasive bladder cancer
- Metastatic castration-resistant prostate cancer
- Biochemically recurrent prostate cancer
The investigator works with novel therapeutic approaches including immunotherapy combinations and targeted treatments for urological malignancies.
Kidney Cancer
Extensive involvement in renal cell carcinoma research, focusing on both localized and metastatic disease states.
- Advanced renal cell carcinoma
- Metastatic renal cell carcinoma
- Clear cell renal cancer
- Oligometastatic renal cell carcinoma
The investigator explores innovative treatment combinations including immunotherapy and targeted therapies for kidney cancer.
Gynecologic Oncology
Research focus includes treatment of ovarian cancer and related gynecologic malignancies.
- High-grade serous ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
- Uterine serous carcinoma
The investigator studies novel therapeutic approaches for advanced and recurrent gynecologic cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.